Executive Director, Portfolio Systems & Strategy Integration
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
This is a unique and high-impact opportunity to help shape how a rapidly growing oncology company manages its pipeline, prioritizes decisions, and integrates strategic intelligence across its portfolio. Revolution Medicines is at an inflection point — with a growing clinical pipeline, increasing organizational complexity, and significant decisions ahead around program advancement, resource allocation, and competitive positioning. This role sits at the center of that work.
The Senior/Executive Direct
